Low cost, max effects? Korean firm Navipharm developing duo-strain product

amid 'pharmmabiotics' ambitions

South korean firm Navipharm is focusing its R&D efforts on duo-strain probiotics products, after conducting research that appears to show that they are as efficacious, and more cost effective, as compared to multi-strain product.
By Tingmin Koe | 14-Sep-2021
 

[Source : NUTRA ingredients-asia.com] Click to read an original article